
Compared with placebo, dupilumab led to significant improvements in caregiver-reported atopic dermatitis symptoms and quality of life as early as week 4, with sustained benefits throughout the study period: bit.ly/4pUbm8s

English
JAAD Journals
10.1K posts

@JAADjournals
Clinical cases and the latest research from Journal of the American Academy of Dermatology (JAAD), JAAD Case Reports, and JAAD International.










































